Globus Medical, Inc.

Globus Medical, Inc.

GMED·NYSE

$77.95

-0.38%
HealthcareMedical - Devices

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$10.51B
EPS3.9800
P/E Ratio19.59
Earnings Date07/30/2026
8.78%
Return on Invested Capital
201%
3Y-6.0%
5Y+51.0%
10Y-27.0%
11.76%
Return on Equity
377%
3Y+14.0%
5Y+73.0%
10Y-6.0%
10.14%
Return on Assets
417%
3Y+11.0%
5Y+67.0%
10Y-10.0%
Globus Medical, Inc.

Globus Medical, Inc. Management Team

GMED · NYSE
MK

Mr. Keith W. Pfeil

Chief Executive Officer, President & Director

Compensation

$1,104,613

Born 1979(Age 47)
male
MK

Mr. Keith W. Pfeil

Chief Financial Officer & Chief Operating Officer

Compensation

$1,104,613

Born 1979(Age 47)
male
MD

Mr. David C. Paul

Co-Founder & Chairman

Compensation

$1,486,468

Born 1967(Age 59)
male
MD

Mr. David C. Paul

Co-Founder & Executive Chairman

Compensation

$1,486,468

Born 1967(Age 59)
male
MK

Ms. Kelly G. Huller Esq.

Executive Vice President, General Counsel & Corporate Secretary

Compensation

$789,513

Born 1972(Age 54)
female
MD

Mr. Daniel T. Scavilla

President, Chief Executive Officer & Director

Compensation

$1,921,774

Born 1965(Age 61)
male
MK

Mr. Kyle Kline

Senior Vice President & Chief Financial Officer

Born 1985(Age 41)
male
MB

Mr. Brian J. Kearns

Senior Vice President of Business Development & Investor Relations

Born 1967(Age 59)
male
gmed

Globus Medical, Inc. Insider Positioning

GMED · NYSE

During the last 12 months, insiders have sold $11.69M worth of GMED shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

39.6K

3.69M

Net Activity

-3.7M

-$3.69M

6-9 Months

Bought

0

0.00

Sold

96.0K

8.00M

Net Activity

-8.0M

-$8.00M

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
HK

Huller Kelly

Officer: Evp, Gc, Corporate Secretary

37.5K shares3 transactions

$3.44M

2
DDD

Davidar David D

Director

25.0K shares1 transactions

$2.15M

3
ZST

Zarrilli Stephen T

Director

25.0K shares1 transactions

$2.11M

4
KK

Kline Kyle

Officer: Senior Vice President, Cfo

22.1K shares2 transactions

$2.03M

5
RAD

Rhoads Ann D

Director

20.0K shares3 transactions

$1.40M

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $11.69M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

SEC Filings

GMED - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 24, 2026
June 03, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 25, 2025
June 04, 2025
2025
DEF 14A

DEF 14A 2023

N/A

April 26, 2024
December 31, 2023
2023
DEF 14A

DEF 14A

N/A

April 28, 2023
April 28, 2023
 
DEF 14A

DEF 14A 2022

N/A

April 21, 2022
April 21, 2022
2022
DEF 14A

DEF 14A 2020

N/A

April 22, 2021
December 31, 2020
2020
DEF 14A

DEF 14A 2020

N/A

April 23, 2020
April 23, 2020
2020
DEF 14A

DEF 14A 2018

N/A

April 25, 2019
December 31, 2018
2018
DEF 14A

DEF 14A 2017

N/A

April 26, 2018
December 31, 2017
2017
DEF 14A

DEF 14A 2016

N/A

April 27, 2017
December 31, 2016
2016
Showing 1 to 10 of 14 filings